The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Cancer

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejca.2011.04.028PMID 21621407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antitumour activity of NK012, SN-38-incorporating polymeric micelles, in hypovascular orthotopic pancreatic tumour.

  2010cited by this paper
• Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.

  2008cited by this paper
• The FVIIa-tissue factor complex induces the expression of MMP7 in LOVO cells in vitro

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Trousseau's syndrome: multiple definitions and multiple mechanisms.

  2007cited by this paper
• Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer

  2007cited by this paper
• Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells.

  2006cited by this paper
• Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.

  2006cited by this paper
• Incidence of venous thromboembolism in patients hospitalized with cancer.

  2006cited by this paper
• Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.

  2005cited by this paper
• Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer

  2005cited by this paper
• Prognostic Significance of Tissue Factor in Pancreatic Ductal Adenocarcinoma

  2005cited by this paper
• Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.

  2004cited by this paper
• Amplification of MMP‐2 and MMP‐9 production by prostate cancer cell lines via activation of protease‐activated receptors

  2004cited by this paper
• An Orthotopic Nude Mouse Model for Evaluating Pathophysiology and Therapy of Pancreatic Cancer

  2003cited by this paper
• The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

  2003cited by this paper
• Histologic Features of Venous Invasion, Expression of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9, and the Relation with Liver Metastasis in Pancreatic Cancer

  2002cited by this paper
• Coagulation proteases and human cancer.

  2001cited by this paper
• Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells.

  2000cited by this paper
• Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.

  2000cited by this paper
• Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells.

  2000cited by this paper
• Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.

  2000cited by this paper
• Thrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells.

  1997cited by this paper
• Pancreatic carcinoma in perspective: A continuing challenge

  1996cited by this paper
• Tissue factor expression correlates with histological grade in human pancreatic cancer

  1995cited by this paper
• Structural biology of tissue factor, the initiator of thrombogenesis in vivo 1

  1994cited by this paper
• Pancreatic carcinoma.

  1992cited by this paper
• The Structural Biology of Expression and Function of Tissue Factor

  1991cited by this paper
• A continuing challenge

  1983cited by this paper

• Tissue factor promotes TREX1 protein stability to evade cGAS-STING innate immune response in pancreatic ductal adenocarcinoma

  2024cites this paper
• Targeting cancer-associated fibroblasts in immunotherapy

  2022cites this paper
• Radioimmunotherapy with an 211At‐labeled anti–tissue factor antibody protected by sodium ascorbate

  2021cites this paper
• High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer

  2021cites this paper
• Barriers to antibody therapy in solid tumors, and their solutions

  2021cites this paper
• Development of tissue factor-targeted liposomes for effective drug delivery to stroma-rich tumors.

  2020cites this paper
• EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis

  2020cites this paper
• Reinforcement of antitumor effect of micelles containing anticancer drugs by binding of an anti-tissue factor antibody without direct cytocidal effects.

  2020cites this paper
• Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic cancer.

  2019cites this paper
• Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models

  2019cites this paper
• CAST Diagnostic Imaging

  2019cites this paper
• Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer‐specific molecule

  2019cites this paper
• Treating Tissue Factor–Positive Cancers with Antibody–Drug Conjugates That Do Not Affect Blood Clotting

  2018cites this paper
• Significant antitumour effect of an antibody against TMEM180, a new cancer-specific molecule

  2018cites this paper
• Effect of Tissue Factor on Colorectal Cancer Stem Cells.

  2018cites this paper
• Role of extracellular vesicles , microvascular fibrin formation and immune surveillance in pancreatic cancer metastasis

  2018cites this paper
• The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma

  2018cites this paper
• Influence of the dissociation rate constant on the intra‐tumor distribution of antibody‐drug conjugate against tissue factor

  2018cites this paper
• Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma

  2017cites this paper
• Cancer Stromal Targeting Therapy.

  2017cites this paper
• Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model

  2017cites this paper
• Thrombosis in colorectal cancer

  2016cites this paper
• Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site–Inhibited Factor VII

  2016cites this paper
• Utility of epirubicin‐incorporating micelles tagged with anti‐tissue factor antibody clone with no anticoagulant effect

  2016cites this paper
• Tissue Factor Induced by Epithelial-Mesenchymal Transition Triggers a Procoagulant State That Drives Metastasis of Circulating Tumor Cells.

  2016cites this paper
• Anticoagulants versus cancer.

  2016cites this paper
• Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer.

  2015cites this paper
• Feasibility study of the Fab fragment of a monoclonal antibody against tissue factor as a diagnostic tool.

  2015cites this paper
• Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts

  2015cites this paper
• Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models

  2015cites this paper
• Tissue Factor: Old and New Links with Cancer Biology

  2015cites this paper
• A clinical trial can determine the course of DDS development

  2014cites this paper
• A New Chemiluminescent Enzyme Immunoassay for Plasma Tissue FactorDetection

  2014influential citation
• Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer

  2014cites this paper
• Tissue factor in tumor microenvironment: a systematic review

  2014cites this paper
• Microparticle‐associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features

  2013cites this paper
• Biomarkers for prediction of venous thromboembolism in cancer.

  2013cites this paper
• Clinical Significance of Coagulation Assays in Metastatic Pancreatic Adenocarcinoma

  2013cites this paper
• Therapeutic Discovery Cdk 4 / 6 Inhibition InducesEpithelial – MesenchymalTransition and Enhances Invasiveness in Pancreatic Cancer Cells

  2012cites this paper
• Cdk 4 / 6 Inhibition Induces Epithelial-Mesenchymal Transition and Enhances Invasiveness in Pancreatic Cancer Cells

  2012cites this paper
• Molecular markers for progression of squamous cell carcinoma of the skin

  2012cites this paper
• Tissue factor proangiogenic signaling in cancer progression.

  2012cites this paper
• Cdk4/6 Inhibition Induces Epithelial–Mesenchymal Transition and Enhances Invasiveness in Pancreatic Cancer Cells

  2012cites this paper
• Modeling and Simulation of Procoagulant Circulating Tumor Cells in Flow

  2012cites this paper